Dexcel Company Profile

✉ Email this page to a colleague

DEXCEL has sixteen approved drugs.

There are six US patents protecting DEXCEL drugs.

There are seventeen patent family members on DEXCEL drugs in eight countries and eighteen supplementary protection certificates in six countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dexcel	OMEPRAZOLE	omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	209400-001	Jul 5, 2017		OTC	Yes	Yes	10,076,494	⤷ Try a Trial	Y			⤷ Try a Trial
Dexcel Pharma	OMEPRAZOLE	omeprazole	TABLET, DELAYED RELEASE;ORAL	022032-001	Dec 4, 2007		OTC	Yes	Yes	9,023,391	⤷ Try a Trial	Y			⤷ Try a Trial
Dexcel	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	209193-002	Oct 31, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Dexcel Ltd	ISOSORBIDE MONONITRATE	isosorbide mononitrate	TABLET, EXTENDED RELEASE;ORAL	075522-002	Sep 20, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Dexcel	ESOMEPRAZOLE MAGNESIUM	esomeprazole magnesium	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	214278-001	Oct 20, 2020		DISCN	Yes	No	10,835,488	⤷ Try a Trial	Y			⤷ Try a Trial
Dexcel	VIGABATRIN	vigabatrin	TABLET;ORAL	215109-001	Sep 23, 2021	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dexcel Pharma	PERIOCHIP	chlorhexidine gluconate	TABLET;DENTAL	020774-001	May 15, 1998	5,002,769	⤷ Try a Trial
Dexcel Pharma	PERIOCHIP	chlorhexidine gluconate	TABLET;DENTAL	020774-001	May 15, 1998	5,023,082	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2019123453	⤷ Try a Trial
Austria	390119	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2016174664	⤷ Try a Trial
Israel	130602	⤷ Try a Trial
European Patent Office	3288556	⤷ Try a Trial
Germany	60038447	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1429780	13C0012	France	⤷ Try a Trial	PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
0328535	96C0021	Belgium	⤷ Try a Trial	PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
1411900	SPC/GB11/015	United Kingdom	⤷ Try a Trial	PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
1581193	SPC/GB12/047	United Kingdom	⤷ Try a Trial	PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
0296560	SPC/GB97/023	United Kingdom	⤷ Try a Trial	PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214
1129088	2014/008	Ireland	⤷ Try a Trial	PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.